ZUG, Switzerland, Nov. 29, 2024 (GLOBE NEWSWIRE) — The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares.
Attachments
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care…
SHEFFIELD, United Kingdom, Jan. 8, 2025 /PRNewswire/ -- BlackfinBio Ltd (BFB) a clinical stage gene therapy…
RANCHO CUCAMONGA, CA / ACCESSWIRE / January 8, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced…
LONDON, UK / ACCESSWIRE / January 8, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased…
PhenQ is a natural weight management system that targets five major areas of metabolic health,…
Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…